Cicor Technologies Ltd banner

Cicor Technologies Ltd
F:CRLN

Watchlist Manager
Cicor Technologies Ltd Logo
Cicor Technologies Ltd
F:CRLN
Watchlist
Price: 123.4 EUR 1.48%
Market Cap: €576.3m

Cicor Technologies Ltd
Investor Relations

Cicor Technologies is a contract manufacturer and engineering partner for electronic products. It designs and builds printed circuit boards, assembled electronic modules, and related plastic and microelectronic parts for other companies, rather than selling finished consumer brands under its own name. Its customers are mainly industrial, medical, aerospace, defense, and other equipment makers that need reliable electronics inside their products. Cicor makes money by charging for development work, production, assembly, and the supply of custom parts and systems built to a customer’s specifications. What sets Cicor apart is its role deep in the supply chain: it helps customers turn an electronics design into a manufacturable product and then produces it over time. That makes the business less about one-time product sales and more about long-term manufacturing relationships, where precision, quality control, and technical know-how matter more than branding.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2023
Call Date
Jul 25, 2023
AI Summary
Q2 2023

Strong Growth: Cicor reported first half 2023 revenue of CHF 199 million, up 26.2%, with organic growth of 9.5% despite a challenging economic environment.

Profitability: EBITDA rose 42% to CHF 21.3 million (margin 10.7%), driven mainly by the EMS segment and improved pricing.

Cash Flow: Supply chain tensions eased, enabling a return to positive free cash flow of CHF 5.2 million in the first half.

Raised Guidance: Full-year sales guidance increased to CHF 380–410 million and operating result guidance to CHF 40–45 million, reflecting strong business momentum.

Strategic Focus: Management emphasized continued focus on core markets (medical, aerospace & defense, industrial) and successful integration of recent acquisitions.

Order Book: Book-to-bill was 1.1, indicating robust demand and a growing order backlog.

Key Financials
Revenue
CHF 199 million
EBITDA
CHF 21.3 million
EBITDA Margin
10.7%
Organic Growth
9.5%
Book-to-Bill
1.1
Free Cash Flow (pre-acquisition)
CHF 5.2 million
Core EBIT
7.6% of sales
Core Net Profit
CHF 9.2 million
Core Earnings per Share
CHF 2.08
Leverage
1.55
Equity Ratio
38%
Sales Guidance (2023)
CHF 380–410 million
Operating Result Guidance
CHF 40–45 million
Other Earnings Calls
2023

Management

Mr. Alexander Hagemann
CEO & Member of Management Board
No Bio Available
Mr. Peter Neumann C.F.A.
CFO & Member of the Management Board
No Bio Available
Mr. Marco Kechele
COO & Member of Management Board
No Bio Available
Mr. Michael Gotti
Vice President of Corporate Marketing & Communications
No Bio Available
Dr. Urs Wehinger
Secretary
No Bio Available

Contacts

Address
NEUCHATEL
Boudry
Route de lEurope 8
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett